BioNexus Gene Lab (BGLC) Revenue (2018 - 2026)

BioNexus Gene Lab's Revenue history runs 9 years deep, the most recent figure standing at $22842.0 for Q1 2026.

• In Q1 2026, Revenue fell 98.93% year-over-year to $22842.0; the TTM figure through Mar 2026 stood at $5.3 million (down 42.69% YoY), while the FY2025 annual figure was $7.4 million, down 21.93% from the prior year.
• Revenue came in at $22842.0 for Q1 2026 at BioNexus Gene Lab, down from $483760.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $3.0 million in Q1 2022 to a low of $22842.0 in Q1 2026.
• A 5-year average of $2.2 million and a median of $2.5 million in 2022 frame the typical range for Revenue.
• Across the five-year window, Revenue rose 14.47% in 2025 and plunged 98.93% in 2026, its largest moves.
• BioNexus Gene Lab's Revenue stood at $2.8 million in 2022, then declined by 19.95% to $2.3 million in 2023, then gained by 11.03% to $2.5 million in 2024, then sank by 80.83% to $483760.0 in 2025, then sank by 95.28% to $22842.0 in 2026.
• According to Business Quant data, Revenue over the past three periods registered $22842.0, $483760.0, and $2.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison